<DOC>
	<DOC>NCT02908282</DOC>
	<brief_summary>The primary objective of this study is to evaluate the efficacy of REMOGEN® OMEGA in reducing Dry Eye Syndrome (DES) symptoms.</brief_summary>
	<brief_title>Topical Omega-3 Fatty Acids (REMOGEN® OMEGA) in the Treatment of Dry Eye</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Povidone</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Male or female patient between 18 and 80 years of age and in good general health condition. Signed written informed consent. Existence of moderate to severe DES symptoms defined as Breakup time (TBUT) ≤ 10 s (mean of 3 consecutive measurements) and OSDI questionnaire ≥ 20. Contraindication for the use of the products (e.g. hypersensitivity to the constituents of the test products) or any study procedure. Concomitant or previous participation in a clinical investigation within the last 3 months. Concomitant therapies/manipulations that affect either the tear film, tear secretion or ocular surface integrity or would alter the effect of the devices being evaluated. Concurrent (systemic) DESassociated diseases that are not on a stable therapy since at least 1 month (therapy not expected to change) Glaucoma that is not on a stable dosage since at least 2 weeks (therapy not expected to change) Any diseases or characteristics judged by the investigator to be incompatible with the assessments and/or procedures for the study evaluation Pregnant or lactating females. Participants of childbearing age who do not use adequate methods of birth control. Subjects unable to understand the informed consent or having a high probability of noncompliance to the study procedures and/or noncompletion of the study according to investigator's judgment (e.g. illiteracy, insufficient knowledge of local language). Subjects not capable of contracting and of understanding the nature, risks, significance and implications of the clinical investigation and unable to form a rational intention in the light of these facts.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>81 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>tear film</keyword>
	<keyword>omega-3 fatty acids</keyword>
	<keyword>eye drops</keyword>
</DOC>